Ovseiko Pavel V, Edmunds Laurel D, Pololi Linda H, Greenhalgh Trisha, Kiparoglou Vasiliki, Henderson Lorna R, Williamson Catherine, Grant Jonathan, Lord Graham M, Channon Keith M, Lechler Robert I, Buchan Alastair M
Medical Sciences Division, University of Oxford, John Radcliffe Hospital, Oxford, UK.
National Initiative on Gender, Culture and Leadership in Medicine: C-Change, Brandeis University Women's Studies Research Center, Waltham, Massachusetts, USA.
BMJ Open. 2016 Jan 7;6(1):e009022. doi: 10.1136/bmjopen-2015-009022.
Translational research organisations (TROs) are a core component of the UK's expanding research base. Equity of career opportunity is key to ensuring a diverse and internationally competitive workforce. The UK now requires TROs to demonstrate how they are supporting gender equity. Yet, the evidence base for documenting such efforts is sparse. This study is designed to inform the acceleration of women's advancement and leadership in two of the UK's leading TROs--the National Institute for Health Research (NIHR) Biomedical Research Centres (BRCs) in Oxford and London--through the development, application and dissemination of a conceptual framework and measurement tool.
A cross-sectional retrospective evaluation. A conceptual framework with markers of achievement and corresponding candidate metrics has been specifically designed for this study based on an adapted balanced scorecard approach. It will be refined with an online stakeholder consultation and semistructured interviews to test the face validity and explore practices and mechanisms that influence gender equity in the given settings. Data will be collected via the relevant administrative databases. A comparison of two funding periods (2007-2012 and 2012-2017) will be carried out.
The University of Oxford Clinical Trials and Research Governance Team and the Research and Development Governance Team of Guy's and St Thomas' National Health Service (NHS) Foundation Trust reviewed the study and deemed it exempt from full ethics review. The results of the study will be used to inform prospective planning and monitoring within the participating NIHR BRCs with a view to accelerating women's advancement and leadership. Both the results of the study and its methodology will be further disseminated to academics and practitioners through the networks of collaborating TROs, relevant conferences and articles in peer-reviewed journals.
转化研究组织（TROs）是英国不断扩大的研究基础的核心组成部分。职业机会平等是确保拥有多样化且具有国际竞争力的劳动力的关键。英国现在要求转化研究组织展示其如何支持性别平等。然而，记录此类努力的证据基础却很薄弱。本研究旨在通过开发、应用和传播一个概念框架及测量工具，为加速英国两个领先的转化研究组织——牛津和伦敦的国家卫生研究院（NIHR）生物医学研究中心（BRCs）中女性的职业发展和领导力提供信息。
一项横断面回顾性评估。基于一种经过调整的平衡计分卡方法，专门为本研究设计了一个带有成就标志和相应候选指标的概念框架。将通过在线利益相关者咨询和半结构化访谈对其进行完善，以测试表面效度，并探索在给定环境中影响性别平等的实践和机制。数据将通过相关行政数据库收集。将对两个资助期（2007 - 2012年和2012 - 2017年）进行比较。
牛津大学临床试验与研究治理团队以及盖伊和圣托马斯国民健康服务（NHS）基金会信托的研发治理团队对该研究进行了审查，并认为其无需进行全面伦理审查。该研究结果将用于为参与研究的NIHR生物医学研究中心的前瞻性规划和监测提供信息，以期加速女性的职业发展和领导力提升。研究结果及其方法都将通过合作的转化研究组织网络、相关会议以及同行评审期刊上的文章进一步传播给学者和从业者。
